0000000000770778

AUTHOR

Giovanni Martinotti

showing 4 related works from this author

Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Ne…

2022

Introduction: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice. Method: In a naturalistic national cohort of 449 patients who initiated LAI treatment in the STAR Network Depot Study, two groups were identified based on off– or on–label prescriptions. A multivariate logistic regression analysis was used to test several clinically relevant variables and identify those associated with th…

Long-acting injectable antipsychoticCross-Sectional StudiesOff-labelPersonality disorderBipolar disorderDelayed-Action PreparationsSchizophreniaHumansBipolar disorder; Long-acting injectable antipsychotics; Off-label; Personality disorder; Schizophrenia; Cross-Sectional Studies; Delayed-Action Preparations; Humans; Off-Label Use; Antipsychotic Agents; SchizophreniaOff-Label UseSettore MED/25 - PsichiatriaLong-acting injectable antipsychoticsAntipsychotic Agents
researchProduct

Transcranial Electrical and Magnetic Stimulation (tES and TMS) for Addiction Medicine: A Consensus Paper on the Present State of the Science and the …

2019

International audience; There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment option for substance-use disorders (SUDs). Recent momentum stems from a foundation of preclinical neuroscience demonstrating links between neural circuits and drug consuming behavior, as well as recent FDA-approval of NIBS treatments for mental health disorders that share overlapping pathology with SUDs. As with any emerging field, enthusiasm must be tempered by reason; lessons learned from the past should be prudently applied to future therapies. Here, an international ensemble of experts provides an overview of the state of transcranial-electrical (tES) and transcranial-magnetic…

Outcome Assessment[SDV]Life Sciences [q-bio]ReviewTranscranial Direct Current StimulationtDCSBehavioral Neuroscience0302 clinical medicineOutcome Assessment Health CarerTMSState of the sciencetEShealth care economics and organizationsmedia_commonCognitive sciencePsychiatryNIBS*tESNeuromodulation (medicine)3. Good healthSystematic reviewNeuropsychology and Physiological PsychologyPractice Guidelines as TopicPsychologyAddiction MedicineTranscranial electrical stimulationSubstance-Related DisordersSettore MED/12 - GASTROENTEROLOGIABest practicemedia_common.quotation_subjectCognitive NeuroscienceAddictionSubstance use disorderArticle03 medical and health sciences*Non-invasive brain stimulation*Transcranial magnetic stimulationHumansNon-invasive brain stimulation*Substance use disorderAddictionMental health*Addiction030227 psychiatry*NIBSHealth CareAddiction medicine*tDCSBrain stimulation*Transcranial electrical stimulation*Psychiatry*rTMS030217 neurology & neurosurgeryTranscranial magnetic stimulation
researchProduct

Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance

2020

As a response to the COVID-19 pandemic, many governments have introduced steps such as spatial distancing and “staying at home” to curb its spread and impact. The fear resulting from the disease, the ‘lockdown’ situation, high levels of uncertainty regarding the future, and financial insecurity raise the level of stress, anxiety, and depression experienced by people all around the world. Psychoactive substances and other reinforcing behaviors (e.g., gambling, video gaming, watching pornography) are often used to reduce stress and anxiety and/or to alleviate depressed mood. The tendency to use such substances and engage in such behaviors in an excessive manner as putative coping strategies i…

ConsensusDistancingSocial connectednesslcsh:RC435-571Internet privacyPneumonia Viral610 Medicine & healthAnxietyArticleSocial group03 medical and health sciences2738 Psychiatry and Mental HealthBetacoronavirus0302 clinical medicinelcsh:PsychiatryPandemicAdaptation PsychologicalmedicinePornographyHumans10064 Neuroscience Center ZurichSalut mentalPandemicsInternetbusiness.industryDepressionSARS-CoV-23203 Clinical PsychologyClinical Psychology; Psychiatry and Mental health; COVID-19COVID-1910058 Department of Child and Adolescent PsychiatryAnxiety Disorders030227 psychiatryPsychiatry and Mental healthClinical PsychologyWork (electrical)PsychologieVideo GamesInformation and Communications Technology10076 Center for Integrative Human PhysiologyAnxietyMental healthmedicine.symptomPsychologybusinessCoronavirus Infections030217 neurology & neurosurgeryComprehensive Psychiatry
researchProduct

Data from: Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy

2019

Background. For many years, long-acting intramuscular (LAI) antipsychotics have been prescribed predominantly to chronic and severe patients, as a last resort when other treatments failed. Recently, a broader and earlier use of LAIs, particularly second-generation LAIs, has been emphasized. To date, few studies attempted to frame how this change in prescribing took place in real-world practice. Therefore, this study aimed to describe the clinical features of patients prescribed with LAIs, and to explore possible prescribing differences between first- and second-generations LAIs under ordinary clinical practice in Italy. Methods. The STAR Network "Depot" Study is an observational, longitudin…

bipolar disorderpharmacoepidemiologyvirusesLife Sciencesvirus diseaseslong-acting injectable antipsychoticsadherence to antipsychoticsDecember 2015-May 2017medicine and health careschizophreniaantipsychoticsimmune system diseasesMedicineoff-label prescriptionsdepot antipsychotics
researchProduct